This site uses cookies to improve your browsing experience. By using this site, you agree to their use. Cookie Information
Login or create an account to see restricted content
Login or RegisterOne of the main aims of treatment in T2D is to reduce the risk of vascular complications. Glucose control helps to reduce microvascular complications, but its impact on macrovascular outcomes remains uncertain. Patients with T2D may therefore require additional CV risk factor control.
This module explains the purpose, method, interpretation and potential
This module summarises recent changes to global diabetes, cardiovascul
This interactive module explores the care of a patient whose T2D was d
Obesity is an indicator of high risk for ASCVD. This interactive modul
This module outlines SGLT2 inhibitor CVOT data, safety information and
This module summarises current practical guidance, evidence and recomm
This module summarises recent guidance for healthcare professionals
PAD is a complication of T2D and a predictor of CV events. This intera
Patients with T2D have a risk of CV and kidney events. This interactiv
This module summarises evidence from cardiovascular outcomes trials (C
Numerous sources of clinical data are used to inform clinical practice
Type 2 diabetes is a strong independent risk factor for cardiovascular